Redcare Pharmacy NV Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Redcare Pharmacy NV stock has a consensus rating of "Buy" and an average price target of €79.67. The average 1-year stock price forecast is 17.33% higher than the current stock price, while the lowest is €55.00 (-19.00%) and the highest is €102.00 (+50.22%).

Price Target: €79.67 (+17.33%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	€55.00	€79.67	€83.00	€102.00
Change	-19.00%	+17.33%	+22.24%	+50.22%

Analyst Ratings

The average analyst rating for Redcare Pharmacy NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	4	4	4	4
Buy	2	2	2	2	2	2
Hold	2	2	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gerhard Orgonas Berenberg Bank	Berenberg Bank	Buy Maintains €87.50 → €92.00	Buy	Maintains	€87.50 → €92.00	+35.49%	Jun 18, 2026
Volker Bosse Baader Bank	Baader Bank	Buy Maintains €85.00	Buy	Maintains	€85.00	+25.18%	Jun 16, 2026
Jan Koch Deutsche Bank	Deutsche Bank	Buy Maintains €99.00 → €102.00	Buy	Maintains	€99.00 → €102.00	+50.22%	Jun 16, 2026
Guillaume Galland Barclays	Barclays	Buy Maintains €70.00 → €75.00	Buy	Maintains	€70.00 → €75.00	+10.46%	Jun 16, 2026
Olivier Calvet UBS	UBS	Hold Maintains €55.00 → €60.00	Hold	Maintains	€55.00 → €60.00	-11.63%	Jun 16, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.40B

from 2.94B

15.65%

from 2.94B

Revenue Next Year

3.79B

from 3.40B

11.53%

from 3.40B

EPS This Year

-0.89

from -1.40

EPS Next Year

0.99

from -0.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.06B	1.20B	1.80B	2.37B	2.94B	3.40B
Revenue Growth	9.53%	13.58%	49.36%	31.79%	24.06%	15.65%
Gross Profit	266.80M	331.79M	440.38M	545.80M	663.10M	758.57M
Gross Margin	25.16%	27.55%	24.48%	23.02%	22.55%	22.30%
Operating Income	-32.25M	-47.23M	-3.79M	-39.00M	-20.10M	15.68M
Net Income	-74.19M	-77.65M	-12.04M	-45.50M	-37.70M	-16.26M
EPS	-	-	-	-	-1.40	-0.89
Free Cash Flow	4.22M	-53.42M	-7.65M	-1.95M	-90.50M	9.00M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	3.4B
Avg	3.4B
Low	3.3B

Revenue Growth

Revenue Growth	2026	2027	2028
High	17.0%
Avg	15.7%
Low	13.0%

EPS Forecast

EPS	2026	2027	2028
High	-0.67
Avg	-0.89
Low	-1.11

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-